Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advisory Cmte. Chair Conflicts Of Interest Bar His Vote On Pfizer’s Exubera

Executive Summary

Conflicts of interest caused Nelson Watts (University of Cincinnati Bone Health) to be recused as chair of the Endocrinologic & Metabolic Drugs Advisory Committee and barred from voting during the committee's Sept. 8 review of Pfizer/Sanofi-Aventis' inhaled insulin Exubera
Advertisement

Related Content

Study Involvement Is Not Conflict For Advisory Cmte Members – FDA’s Temple
Study Involvement Is Not Conflict For Advisory Cmte Members – FDA’s Temple
New FDA Conflict Of Interest Policy Enacted At MT 100 Committee Meeting

Topics

Advertisement
UsernamePublicRestriction

Register

PS046320

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel